Concurrent, 3-times daily ultrafractionated radiation therapy and temozolomide for newly inoperable glioblastoma: TEMOFRAC a phase II trial.
P. D. Beauchesnes
No relevant relationships to disclose
G. Faure
No relevant relationships to disclose
G. Noel
No relevant relationships to disclose
T. Schmitt
No relevant relationships to disclose
L. Martin
No relevant relationships to disclose
L. Taillandier
No relevant relationships to disclose
C. D. Carnin
No relevant relationships to disclose